ADMA Biologics (ADMA) Holds “Hold” Consensus From Wall Street Analysts
Shares of ADMA Biologics Inc (NASDAQ: ADMA) have received an average recommendation of “Hold” from the five ratings firms currently covering the stock, according to MarketBeat Ratings. The breakdown of analyst opinions shows a divided view, with one investment analyst rating the stock with a sell recommendation. Two analysts have assigned a hold recommendation to…